RAYMOND JAMES & ASSOCIATES - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$221,196
+2.8%
10,614
+18.1%
0.00%
Q2 2023$215,167
-87.2%
8,984
-71.4%
0.00%
-100.0%
Q4 2020$1,677,000
+102.5%
31,372
+83.8%
0.00%
+100.0%
Q2 2020$828,000
+1.1%
17,073
-11.9%
0.00%0.0%
Q1 2020$819,000
-12.0%
19,380
-11.0%
0.00%0.0%
Q4 2019$931,000
+83.6%
21,770
+54.4%
0.00%0.0%
Q3 2019$507,000
+28.7%
14,098
-4.3%
0.00%0.0%
Q2 2019$394,000
-16.2%
14,731
-9.6%
0.00%0.0%
Q4 2016$470,000
-1.1%
16,289
-35.9%
0.00%0.0%
Q3 2016$475,000
+47.5%
25,393
+29.3%
0.00%0.0%
Q2 2016$322,000
+40.6%
19,644
+139.4%
0.00%0.0%
Q1 2016$229,000
-89.2%
8,204
-86.2%
0.00%
-87.5%
Q4 2015$2,123,000
+13.0%
59,551
+4.8%
0.01%0.0%
Q3 2015$1,879,000
-10.6%
56,807
+13.2%
0.01%0.0%
Q2 2015$2,101,000
+34.7%
50,171
+4.8%
0.01%
+14.3%
Q1 2015$1,560,000
-5.7%
47,876
-8.1%
0.01%
-12.5%
Q4 2014$1,654,00052,1010.01%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders